Sanofi's said on Thursday first-quarter operating income declined 14.7% as unfavourable currency effects and cheap ...
Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidance Paris, Sales growth of 6.7% at CER and business EPS(1) of €1.78 Dupixent sales up 24.9% to ...
Sanofi backed its full-year guidance after first-quarter sales and profit beat analysts expectations. The French pharmaceutical company said Thursday that its business operating profit--one of the ...
French drugmaker Sanofi has asked banks to pitch for roles on the separation of its consumer-health business, according to ...
Sanofi will pay more than $100 million to settle about 4,000 lawsuits accusing the French drugmaker of failing to warn users ...
Sanofi, a drug company that has operations in Monroe County, will report first-quarter 2024 results on Thursday. Paris-based ...
Sanofi will be reporting latest earnings on April 25.Wall Street analysts expect Sanofi will report earnings per share of $0.925.Track Sanofi ...
French drugmaker Sanofi said on Thursday it would restructure the U.S. commercial operations for its vaccines and cut ...
During a busy period of overhaul at Sanofi, the company is restructuring its U.S. vaccine commercial group. | During a busy ...
Data from the Phase III LUNA 3 study on Tuesday showed that Sanofi’s BTK inhibitor rilzabrutinib significantly improved ...
Sanofi’s global collaboration with IGM Biosciences has shrunk by half. The companies will now focus only on developing three ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback